CellaVision AB (publ) (STO:CEVI)
154.40
+1.80 (1.18%)
At close: Mar 9, 2026
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of 3.68 billion as of March 9, 2026. Its market cap has decreased by -21.38% in one year.
Market Cap
3.68B
Enterprise Value
3.55B
Revenue
748.45M
Ranking
n/a
PE Ratio
24.32
Stock Price
154.40
Market Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 372.09M to 3.68B, an increase of 889.72%. That is a compound annual growth rate of 12.98%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xvivo Perfusion AB | 5.74B |
| MedCap AB | 7.37B |
| BICO Group AB | 1.24B |
| Paxman AB | 1.16B |
| Vitrolife AB | 12.68B |
| Nolato AB | 13.75B |
| Sedana Medical AB | 917.87M |
| C-Rad AB | 884.69M |